hero background

ChondroFiller® at the Liquid Cartilage

Injectable, Structural Regenerative Implant for Cartilage Care

Protect • Repair • Regenerate

← Back Home
What recurrent ankle sprains do to cartilage

What recurrent ankle sprains do to cartilage

The cascade from sprain to chronic ankle instability

Keep rolling your ankle? The answer to whether you should worry about long-term damage is yes — and the reason has less to do with any single episode than with what happens across repeated ones.

Ankle sprain is the most common injury in sport, and the typical mechanism is an inversion movement: the foot rolls inward, loading the outer edge of the ankle beyond what the lateral ligaments can tolerate. A first sprain, properly managed, often heals well. The ligaments recover, proprioception returns, and the joint regains its normal stability.

The problem begins when recovery is incomplete. Residual laxity in the lateral ligament complex — even subtle laxity that causes no obvious wobble during daily walking — leaves the ankle in a state called chronic ankle instability (CAI). In this state, the joint no longer moves or loads as it should. Weight carried through each step shifts away from its normal path across the talar dome, and this altered load distribution drives ongoing cartilage wear.

The cycle is self-reinforcing: instability produces abnormal loading; abnormal loading damages cartilage; cartilage damage compromises the joint further. What makes this particularly deceptive is that each subsequent sprain may feel less severe than the last — the body adapts and the drama fades — but the cumulative structural cost accumulates quietly beneath the surface. Recurrence, not severity, is the real warning sign.

Why ankle cartilage cannot repair itself

Ankle sprains damage cartilage through three distinct but overlapping routes: acute shear and impaction forces at the moment of injury, repetitive microtrauma from the ongoing abnormal loading of CAI, and sudden osteochondral fracture. All three target tissue that has almost no capacity to repair itself.

Unlike bone or muscle, articular cartilage has no direct blood supply. It depends entirely on diffusion from the surrounding synovial fluid — a mechanism that sustains healthy tissue but cannot deliver the repair cells that a blood vessel would bring. There is no self-repair crew, so damage accumulates unchecked.

The layered architecture of cartilage amplifies this over time. The tissue runs from a superficial gliding surface through transitional and deep zones down to a calcified layer sitting directly against the subchondral bone. Once disruption passes through that calcified zone, the bone beneath is exposed and deterioration accelerates sharply — the subchondral plate, once breached, is far less forgiving than the cartilage above it.

Cellular failure begins even earlier than imaging suggests: chondrocytes undergo apoptosis, reduce protein synthesis, and lose their structural anchorage in the matrix long before a scan reveals a visible defect.

Left unaddressed, this accumulation may progress to post-traumatic osteoarthritis (PTOA) — a recognised long-term consequence of untreated CAI. That trajectory is not inevitable, but it is substantially easier to interrupt early than to reverse once it is established.

Free non-medical discussion

Not sure what to do next?

Book a Discovery Call

Information only · No medical advice or diagnosis.

Where damage appears — the talar dome and its two subtypes

The damage that accumulates through the sprain–CAI pathway has a characteristic landing point: the dome of the talus, the uppermost bone of the ankle. Osteochondral lesions of the talus (OLTs) is the clinical label for combined cartilage and underlying bone damage at this site, and the talar dome's two sides tend to produce slightly different injury patterns.

Lateral dome lesions are typically linked to acute shear forces at the moment of inversion — the same forces that stretch or tear the lateral ligaments — and tend to appear on the anterolateral surface. Medial dome lesions are more often a product of chronic compressive microtrauma from ongoing instability, clustering on the posteromedial surface. Both subtypes can coexist in patients with long-standing CAI, and either will continue to progress if the underlying instability goes unaddressed. The evidence on which patients develop medial versus lateral lesions, and at what rates, is still being refined — the anatomical pattern is recognised, but subtype cannot reliably be predicted from instability history alone.

For a patient at the assessment stage, the practical point is simpler: both subtypes follow the same sprain–CAI pathway described above, both respond to the same staging framework, and both warrant early specialist evaluation rather than watchful waiting.

How lesion severity is graded

A referral letter that reads 'Grade 2 OLT, 1.8 cm²' can look opaque without a framework to interpret it. The grading system describes how deeply the lesion penetrates the cartilage layer. Grade 1 means the surface is still intact — the tissue is softened or blistered but structurally continuous. Grade 2 signals damage through less than half the cartilage depth. Grade 3 extends beyond the halfway point, with sub-grades tracking how close the disruption has come to the calcified zone and the subchondral bone beneath. Grade 4 is a full-thickness breach: the underlying bone is exposed.

Defect size adds a second, equally important dimension. The threshold of approximately 2–4 cm² carries real clinical weight: lesions below it may respond to marrow stimulation techniques, while larger defects are more likely to need cell-based or osteochondral transplant strategies. A Grade 3 defect measuring 1 cm² and a Grade 3 defect measuring 5 cm² are not the same clinical problem, even though the depth classification is identical.

Symptoms tend to track severity in broad terms. Earlier lesions typically produce pain that comes on with activity and settles with rest. Later stages — particularly where cartilage fragments begin to move — bring joint effusion, a catching sensation, or outright locking of the ankle.

Importantly, not every OLT found on imaging causes symptoms. An incidental finding on an MRI scan is not automatically a treatment mandate. Specialist interpretation of the full clinical picture — symptoms, instability history, functional limitations, and imaging together — determines whether and how to intervene.

The imaging pathway for ankle cartilage assessment

A clear X-ray is not the same as a clear ankle. Bone shows up well on plain radiographs; cartilage does not. So when a GP-requested X-ray comes back unremarkable after a recurrent sprain, that result rules out fracture — it does not rule out the cartilage or soft-tissue damage that may be driving the symptoms.

Stress-view radiographs are a useful first step beyond the standard plain film. By applying controlled load to the ankle during imaging, they capture ligamentous laxity that a resting X-ray cannot, helping to establish whether chronic instability is present and providing a documented baseline for the consultation.

Where more detail is needed, CT scanning offers precise definition of bony architecture. It quantifies lesion size, maps the subchondral bone layer in multiple planes, and provides the information a surgeon would need for preoperative planning. Plantar-flexion CT views can also indicate how accessible a lesion would be via arthroscope, should that route be considered.

MRI is the modality of choice when cartilage or a non-displaced fragment is the concern. Lesions that are entirely invisible on X-ray and CT — particularly early-stage softening or subchondral oedema — can be identified on MRI with high sensitivity. It gives the most complete picture of lesion extent across both the cartilage layer and the bone beneath it.

The three modalities answer different questions and are routinely used in sequence rather than as alternatives. Imaging is, in any case, one input into the assessment. Clinical history — how the instability has evolved, what movements provoke pain, how function has changed — and physical examination remain essential. A scan seen in isolation, without that context, rarely tells the whole story.

When to seek a specialist and what the pathway looks like

Three sprains in two years, each followed by persistent swelling and a sense that the ankle gives way — that pattern is worth acting on, not waiting out.

The signal to seek a specialist opinion is straightforward: symptoms that have not settled after six to eight weeks of appropriate conservative management, an ankle that continues to give way on uneven ground, or any episode of joint swelling, catching, or locking. These features suggest that instability has moved beyond a single soft-tissue episode and may reflect the structural changes discussed earlier in this article.

Conservative care remains first-line. Structured physiotherapy — targeting proprioception, peroneal muscle strength, and neuromuscular control — alongside bracing and load modification can restore stability and reduce abnormal joint loading before cartilage wear becomes established. Many patients recover well without further investigation or intervention.

Where imaging confirms a focal talar cartilage lesion, the treatment spectrum widens. Smaller, earlier-stage lesions may respond to physiotherapy and injection-based support. Injectable collagen scaffolds — ChondroFiller injection is one such option available in the UK — offer a minimally invasive, outpatient route for eligible focal defects: ultrasound-guided placement with no theatre admission required. Higher-grade or larger defects may need marrow stimulation or osteochondral transplant, with lesion grade and defect area the principal deciding factors.

The broader point is that pattern matters more than any single episode. Articular cartilage cannot reliably signal its own deterioration until damage is already established, which is why persistent or recurrent instability warrants a specialist assessment rather than repeated periods of watchful waiting.

Patients in London seeking that assessment can consult the London Cartilage Clinic on Harley Street, which provides evaluation of ankle cartilage and instability and access to injectable scaffold pathways — details at londoncartilage.com.

  1. [1] Sprained Ankle — Wikipedia. https://en.wikipedia.org/?curid=5701744 https://en.wikipedia.org/?curid=5701744
  2. [2] Sprain — Wikipedia. https://en.wikipedia.org/?curid=390757 https://en.wikipedia.org/?curid=390757
  3. [3] Knee Cartilage Replacement Therapy — Wikipedia. https://en.wikipedia.org/?curid=4984243 https://en.wikipedia.org/?curid=4984243
  4. [4] Osteochondritis Dissecans — Wikipedia. https://en.wikipedia.org/?curid=3762029 https://en.wikipedia.org/?curid=3762029

Frequently Asked Questions

  • Chronic ankle instability occurs when ankle ligaments do not heal properly after a sprain, leaving residual laxity. This causes abnormal joint movement and altered weight distribution away from the normal path across the talar dome, driving ongoing cartilage wear.
  • Ankle cartilage lacks direct blood supply and depends entirely on diffusion from synovial fluid. This sustains healthy tissue but cannot deliver the repair cells a blood vessel would bring, so damage accumulates unchecked.
  • Lateral dome lesions result from acute shear forces during inversion, appearing on the anterolateral surface. Medial dome lesions develop from chronic compressive microtrauma in longstanding instability, clustering on the posteromedial surface.
  • Grades 1–4 describe penetration depth, from intact surface to full-thickness with exposed bone. Defect size (approximately 2–4 cm²) matters equally: lesions below this may respond to marrow stimulation, whilst larger ones typically need cell-based or transplant strategies.
  • Seek specialist evaluation if symptoms persist after six to eight weeks of conservative care, the ankle continues giving way on uneven ground, or there is joint swelling, catching, or locking. These suggest structural changes beyond a single soft-tissue injury.

Legal & Medical Disclaimer

This article is written by an independent contributor and reflects their own views and experience, not necessarily those of Liquid Cartilage. It is provided for general information and education only and does not constitute medical advice, diagnosis, or treatment.

Always seek personalised advice from a qualified healthcare professional before making decisions about your health. Liquid Cartilage accepts no responsibility for errors, omissions, third-party content, or any loss, damage, or injury arising from reliance on this material.

If you believe this article contains inaccurate or infringing content, please contact us at [email protected].

Last reviewed: 2026For urgent medical concerns, contact your local emergency services.
Patient recovering with guidance

Take the Next Step

Cartilage damage won’t reverse on its own—yet with the right plan it can beprotected, repaired, and regenerated.

At Liquid Cartilage, you access world-leading science and a joint-preservation vision on Harley Street.

  • Start with a Discovery Call.
  • Or book your Consultation with Prof. Lee today.

(Consultation fee credited towards treatment if you proceed.)

Verified by DoctifyVerified by Doctify

Latest Blog

View all →
What recurrent ankle sprains do to cartilage
17 Jul 2026

What recurrent ankle sprains do to cartilage

Incomplete ankle sprain recovery leaves residual laxity and abnormal joint loading, triggering self-reinforcing cartilage damage; recurrence matters more than severity, with structural harm accumulating across successive injuries.

ChondroFiller injection or osteochondral allograft
17 Jul 2026

ChondroFiller injection or osteochondral allograft

Cartilage defects confined to the joint surface—with intact subchondral bone—can be treated via outpatient injection of a collagen scaffold. Those extending into bone require surgical transplantation of donor tissue to restore both the cartilage and structural layer beneath.

ChondroFiller injection for older patients
17 Jul 2026

ChondroFiller injection for older patients

ChondroFiller injection works as a collagen scaffold that provides immediate cushioning without relying on the body's cellular regeneration, which declines with age — making it suited to older patients even with advanced osteoarthritis where cell-dependent procedures become less reliable.

ChondroFiller injection outcomes across joint types
16 Jul 2026

ChondroFiller injection outcomes across joint types

ChondroFiller injection achieved mean IKDC improvements of 30 points in knee patients across four studies, exceeding the 16.7-point clinically important threshold in every instance; gains persisted to three years, but longer-term durability remains unestablished.

How a focal knee cartilage defect is diagnosed
16 Jul 2026

How a focal knee cartilage defect is diagnosed

Hyaline articular cartilage contains no nerve fibres or blood vessels, allowing defects to develop silently for months or years; diagnosis depends on MRI assessment of depth, area, and containment, combined with evaluation of alignment and ligament stability.

ChondroFiller injection vs MACI
16 Jul 2026

ChondroFiller injection vs MACI

On the NHS, MACI funding requires all four criteria at once—defect over 2 cm², no prior surgery, minimal arthritis, specialist centre access; missing one bars funding entirely. ChondroFiller injection, entirely self-funded, carries no restrictions and works for advanced arthritis MACI cannot treat.

Privacy & Cookies Policy